Wolverine Trading
CATX icon

Wolverine Trading’s Perspective Therapeutics CATX Stock Holding History

Wolverine Trading’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,140
Closed -$8K – 4465
2016
Q3 		$8K Buy
+1,140
New +$8.69K ﹤0.01% 4538

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's CATX Position: Q4 2016 in Review

Wolverine Trading sold out of Perspective Therapeutics (CATX) in Q4 2016, closing a stake of 1,140 shares — an estimated $8K sold.

Wolverine Trading first reported a position in CATX in Q3 2016 and held it in 1 quarter. The position peaked at $8K in Q3 2016. 30 funds tracked by Wall St. Rank hold CATX as of Q4 2016.

  • Wolverine Trading reported no remaining Perspective Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Wolverine Trading sold 1,140 Perspective Therapeutics shares in Q4 2016, an estimated $8K.
  • Wolverine Trading first reported a position in Perspective Therapeutics in Q3 2016 and held it in 1 quarter.
  • Wolverine Trading's Perspective Therapeutics position peaked at $8K in Q3 2016.
  • 30 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2016.

Based on Wolverine Trading's 13F filing for Q4 2016, filed 14 Feb 2017.